Annual banned-substance review: analytical approaches in human sports drug testing.
暂无分享,去创建一个
Wilhelm Schänzer | Mario Thevis | Hans Geyer | Tiia Kuuranne | M. Thevis | H. Geyer | W. Schänzer | T. Kuuranne
[1] M. Baumstark,et al. Reticulocytes in athletes: Longitudinal aspects and the influence of long- and short-term exercise. , 2010, Drug testing and analysis.
[2] Nicolas V. Schwab,et al. Mass spectrometry made easy: the quest for simplicity. , 2013, Drug testing and analysis.
[3] J. Schulze,et al. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism. , 2015, Drug testing and analysis.
[4] M. Thevis,et al. Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls. , 2013, Drug testing and analysis.
[5] Torben Pottgiesser,et al. Biomarker monitoring in sports doping control. , 2012, Bioanalysis.
[6] F. Agosti,et al. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes. , 2009, European journal of endocrinology.
[7] M. Mazzarino,et al. Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control , 2011, Analytical and bioanalytical chemistry.
[8] C. Reichel. Recent developments in doping testing for erythropoietin , 2011, Analytical and bioanalytical chemistry.
[9] Pierre-Edouard Sottas,et al. Hemoglobin mass and biological passport for the detection of autologous blood doping. , 2012, Medicine and science in sports and exercise.
[10] S. Kageyama,et al. Analysis of non-ketoic steroids 17alpha-methylepithiostanol and desoxymethyl- testosterone in dietary supplements. , 2009, Drug testing and analysis.
[11] M. Thevis,et al. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. , 2011, Rapid communications in mass spectrometry : RCM.
[12] Ó. Pozo,et al. New potential markers for the detection of boldenone misuse , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[13] M. Thevis,et al. Detection of His-tagged Long-R³-IGF-I in a black market product. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[14] Gangfeng Ouyang,et al. Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. , 2012, Journal of chromatography. A.
[15] M. Thevis,et al. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. , 2010, Rapid communications in mass spectrometry : RCM.
[16] M. Galésio,et al. Comparative study of matrices for their use in the rapid screening of anabolic steroids by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.
[17] M. Aşırdizer,et al. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. , 2013, Journal of forensic and legal medicine.
[18] J. Schulze,et al. Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men. , 2011, The Journal of clinical endocrinology and metabolism.
[19] Eileen Y. Robertson,et al. Within-subject variation in hemoglobin mass in elite athletes. , 2012, Medicine and science in sports and exercise.
[20] Ó. Pozo,et al. Stability of selected chlorinated thiazide diuretics. , 2009, Journal of pharmaceutical and biomedical analysis.
[21] D. Gerrard. Drug misuse in sport: a historical perspective. , 2015, The New Zealand medical journal.
[22] Wilhelm Schänzer,et al. Mass Spectrometry-Based Characterization of New Drugs and Methods of Performance Manipulation in Doping Control Analysis , 2010, European journal of mass spectrometry.
[23] C. Saudan,et al. Validation and performance comparison of two carbon isotope ratio methods to control the misuse of androgens in humans. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[24] P. Van Eenoo,et al. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis. , 2008, Journal of chromatography. A.
[25] M. Thevis,et al. Identification of fibroblast growth factor 1 (FGF-1) in a black market product. , 2011, Drug testing and analysis.
[26] M. Meyer,et al. Analytical Toxicology of Emerging Drugs of Abuse—An Update , 2012, Therapeutic drug monitoring.
[27] Serge Rudaz,et al. Sample preparation development and matrix effects evaluation for multianalyte determination in urine. , 2009, Journal of pharmaceutical and biomedical analysis.
[28] M. Thevis,et al. Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing , 2013, Analytical and Bioanalytical Chemistry.
[29] M. Nielen,et al. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.
[30] S. Catalano,et al. Nandrolone and stanozolol induce leydig cell tumor proliferation through an estrogen‐dependent mechanism involving IGF‐I system , 2012, Journal of cellular physiology.
[31] R. Heltsley,et al. Screening indicators of dehydroepiandosterone, androstenedione, and dihydrotestosterone use: a literature review. , 2011, Journal of analytical toxicology.
[32] M. Thevis,et al. Dried blood spots (DBS) for doping control analysis , 2011 .
[33] Ó. Pozo,et al. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection. , 2009, Journal of chromatography. A.
[34] S. Anker,et al. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats , 2013, Journal of cachexia, sarcopenia and muscle.
[35] D. Eichner,et al. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport , 2013, Analytical and Bioanalytical Chemistry.
[36] M. Nielen,et al. High-throughput bioaffinity mass spectrometry for screening and identification of designer anabolic steroids in dietary supplements. , 2013, Analytical chemistry.
[37] F. Lucidi,et al. A call for policy guidance on psychometric testing in doping control in sport. , 2015, The International journal on drug policy.
[38] P. Hemmersbach,et al. Nandrolone: a multi-faceted doping agent. , 2010, Handbook of experimental pharmacology.
[39] Jaeick Lee,et al. Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control. , 2015, Drug testing and analysis.
[40] Mai M H Mansour,et al. The hunt for gene dopers. , 2009, Drug testing and analysis.
[41] L. King,et al. New phenethylamines in Europe. , 2014, Drug testing and analysis.
[42] M. Thevis,et al. Metabolism of growth hormone releasing peptides. , 2012, Analytical chemistry.
[43] K. Deventer,et al. Development of a sensitive GC-C-IRMS method for the analysis of androgens. , 2013, Biomedical chromatography : BMC.
[44] Pierre-Edouard Sottas,et al. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study , 2011, Transfusion.
[45] C. Thompson. New ESA to be available for dialysis patients. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[46] Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories , 2010, Analytical and bioanalytical chemistry.
[47] M. Thevis,et al. Temporal indication of cannabis use by means of THC glucuronide determination. , 2009, Drug testing and analysis.
[48] N. Bachl,et al. Why Glucocorticosteroids Should Remain in the List of Prohibited Substances: A Sports Medicine Viewpoint , 2012, International journal of immunopathology and pharmacology.
[49] J. Pawliszyn,et al. Determination of cocaine and methadone in urine samples by thin-film solid-phase microextraction and direct analysis in real time (DART) coupled with tandem mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.
[50] J. Yli-Kauhaluoma,et al. Synthesis and Characterization of Hydroxylated Mesocarb Metabolites for Doping Control , 2009, Archiv der Pharmazie.
[51] Ó. Pozo,et al. Steroid metabolism in chimeric mice with humanized liver. , 2009, Drug testing and analysis.
[52] R. Ventura,et al. Masking and manipulation. , 2010, Handbook of experimental pharmacology.
[53] C. Reichel,et al. Erythropoietin and analogs. , 2010, Handbook of experimental pharmacology.
[54] P. Sönksen,et al. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection , 2013, Analytical and Bioanalytical Chemistry.
[55] C. Reichel. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. , 2011, Drug testing and analysis.
[56] D. Spandidos,et al. Applications and Biomonitoring Issues of Recombinant Erythropoietins for Doping Control , 2011, Therapeutic drug monitoring.
[57] P. Kavanagh,et al. Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. , 2013, Journal of analytical toxicology.
[58] J. Brugniaux,et al. Hemoglobin and hematocrit are not such good candidates to detect autologous blood doping , 2009, International journal of hematology.
[59] Carsten Lundby,et al. Reticulocyte profile in top-level alpine skiers during four consecutive competitive seasons , 2010, European Journal of Applied Physiology.
[60] M. Thevis,et al. Zeranol: doping offence or mycotoxin? A case-related study. , 2011, Drug testing and analysis.
[61] M. Schäfer,et al. Structure Elucidation of the Diagnostic Product Ion at m/z 97 Derived from Androst-4-en-3-One-Based Steroids by ESI-CID and IRMPD Spectroscopy , 2012, Journal of The American Society for Mass Spectrometry.
[62] M. Thevis,et al. Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls , 2010, Analytical and bioanalytical chemistry.
[63] Serge Rudaz,et al. Analytical aspects in doping control: challenges and perspectives. , 2011, Forensic science international.
[64] K. Gundersen,et al. A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids , 2013, The Journal of physiology.
[65] A. Petróczi,et al. Effects of Dietary Components on Testosterone Metabolism via UDP-Glucuronosyltransferase , 2013, Front. Endocrinol..
[66] S. Bornstein,et al. Pilot Study of Serum Inhibin B as a Potential Marker of Testosterone Doping in Weight Lifting Men , 2010, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[67] U. Mareck,et al. Investigations on changes in ¹³C/¹²C ratios of endogenous urinary steroids after pregnenolone administration. , 2011, Drug testing and analysis.
[68] A. George,et al. Carbon isotope ratio (δ13C) values of urinary steroids for doping control in sport , 2009, Steroids.
[69] Wilhelm Schänzer,et al. Factors influencing the steroid profile in doping control analysis. , 2008, Journal of mass spectrometry : JMS.
[70] Darío Cuervo,et al. An automated sample preparation for detection of 72 doping-related substances. , 2014, Drug testing and analysis.
[71] A. Bauer,et al. Characterization of identity, metabolism and androgenic activity of 17-hydroxyandrosta-3,5-diene by GC–MS and a yeast transactivation system , 2012, Archives of Toxicology.
[72] J. Veuthey,et al. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis. , 2010, Journal of chromatography. A.
[73] T. Hervig,et al. Blood doping: the flip side of transfusion and transfusion alternatives. , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[74] Ó. Pozo,et al. Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism. , 2009, Drug testing and analysis.
[75] C. Saudan,et al. Profiling of 19-norandrosterone sulfate and glucuronide in human urine: Implications in athlete's drug testing , 2009, Steroids.
[76] M. Koupparis,et al. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[77] U. Stenman,et al. Determination of human chorionic gonadotropin. , 2013, Best practice & research. Clinical endocrinology & metabolism.
[78] W. Banks,et al. Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases , 2015, The AAPS Journal.
[79] N. Baume,et al. Influences of β-HCG administration on carbon isotope ratios of endogenous urinary steroids , 2012, Steroids.
[80] K. Ho,et al. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm. , 2009, Drug testing and analysis.
[81] M. Thevis,et al. Clenbuterol - regional food contamination a possible source for inadvertent doping in sports. , 2012, Drug testing and analysis.
[82] P. Marques‐Vidal,et al. Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations. , 2011, Forensic science international.
[83] R. Holt. Detecting growth hormone misuse in athletes , 2013, Indian journal of endocrinology and metabolism.
[84] D. Wells. Gene doping: possibilities and practicalities. , 2009, Medicine and sport science.
[85] M. Thevis,et al. Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes. , 2011, Journal of mass spectrometry : JMS.
[86] A. Nieß,et al. Direct and long-term detection of gene doping in conventional blood samples , 2011, Gene Therapy.
[87] A. Cohen,et al. Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk–benefit , 2013, British journal of clinical pharmacology.
[88] M. Thevis,et al. Detection of recombinant growth hormone in human plasma by a 2‐D PAGE method , 2008, Electrophoresis.
[89] G. Lippi,et al. Controlling sources of preanalytical variability in doping samples: challenges and solutions. , 2013, Bioanalysis.
[90] A. Amoresano,et al. Qualitative screening in doping control by MALDI-TOF/TOF mass spectrometry: a proof-of-evidence. , 2012, Journal of pharmaceutical and biomedical analysis.
[91] J. Veuthey,et al. Analysis of hemoglobin‐based oxygen carriers by CE‐UV/Vis and CE‐ESI‐TOF/MS , 2010, Electrophoresis.
[92] A. Elbe,et al. The Urine Marker Test: An Alternative Approach to Supervised Urine Collection for Doping Control , 2015, Sports Medicine.
[93] D. Kwiatkowska,et al. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose. , 2015, Journal of pharmaceutical and biomedical analysis.
[94] B. Garrido,et al. Detection of designer steroid methylstenbolone in “nutritional supplement” using gas chromatography and tandem mass spectrometry: Elucidation of its urinary metabolites , 2013, Steroids.
[95] R. Boet,et al. Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage. , 2012, Annals of emergency medicine.
[96] M. Ashenden,et al. Screening for Autologous Blood Transfusions , 2009, International journal of sports medicine.
[97] J. V. Sancho,et al. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses. , 2011, Journal of chromatography. A.
[98] C. Gore,et al. Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport , 2011, Journal of Clinical Pathology.
[99] J. V. Sancho,et al. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry , 2009, Steroids.
[100] Grigory Rodchenkov,et al. Detection of JWH-018 metabolites in smoking mixture post-administration urine. , 2010, Forensic science international.
[101] Neil Robinson,et al. The athlete biological passport: an effective tool in the fight against doping. , 2011, Clinical chemistry.
[102] N. Robinson,et al. A high-throughput test to detect C.E.R.A. doping in blood. , 2009, Journal of pharmaceutical and biomedical analysis.
[103] N. Robinson,et al. Effects of Exercise on the Isoelectric Patterns of Erythropoietin , 2009, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[104] P. Hemmersbach,et al. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples. , 2015, Drug testing and analysis.
[105] M. Minunni,et al. Transgene traceability in transgenic mice: a bioanalytical approach for potential gene-doping analysis. , 2011, Bioanalysis.
[106] G. Thiene,et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. , 2012, Forensic science international.
[107] J. Schulze,et al. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes , 2013, European journal of clinical investigation.
[108] Yorck Olaf Schumacher,et al. Scientific expertise and the Athlete Biological Passport: 3 years of experience. , 2012, Clinical chemistry.
[109] M. Thevis,et al. Glycerol administration before endurance exercise: metabolism, urinary glycerol excretion and effects on doping-relevant blood parameters. , 2014, Drug testing and analysis.
[110] L. Reubsaet,et al. Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males , 2013, Analytical and Bioanalytical Chemistry.
[111] Mario Zorzoli,et al. Implementation of the biological passport: the experience of the International Cycling Union. , 2010, Drug testing and analysis.
[112] M. Baron,et al. Keeping pace with NPS releases: fast GC-MS screening of legal high products. , 2013, Drug testing and analysis.
[113] Wilhelm Schänzer,et al. Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. , 2011, Drug testing and analysis.
[114] Mai M H Mansour,et al. Gene doping: of mice and men. , 2009, Clinical biochemistry.
[115] M. Thevis,et al. Comprehensive plasma-screening for known and unknown substances in doping controls. , 2010, Rapid communications in mass spectrometry : RCM.
[116] Ó. Pozo,et al. Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. , 2010, Rapid communications in mass spectrometry : RCM.
[117] D. Gould,et al. Gene doping: Olympic genes for Olympic dreams , 2011, Journal of the Royal Society of Medicine.
[118] Xinxiang Zhang,et al. Quantification of testosterone and epitestosterone in biological samples by capillary electrophoresis with immunoaffinity extraction. , 2009, Talanta.
[119] Mingshe Zhu,et al. First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry , 2013, The AAPS Journal.
[120] C. Georgakopoulos,et al. The effect of fasting during Ramadan on parameters of the haematological and steroidal modules of the athletes biological passport - a pilot study. , 2015, Drug testing and analysis.
[121] J. Mørkeberg. Detection of autologous blood transfusions in athletes: a historical perspective. , 2012, Transfusion medicine reviews.
[122] Leo N. Geppert,et al. Validity of stable isotope data in doping control: perspectives and proposals. , 2012, Drug testing and analysis.
[123] M. Irie,et al. 20K-GH and its use in detecting GH abuse. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[124] Carsten Lundby,et al. Blood doping and its detection. , 2011, Blood.
[125] D. Glez-Peña,et al. Speeding up the screening of steroids in urine: Development of a user-friendly library , 2013, Steroids.
[126] G. Lippi,et al. Ex vivo erythrocyte generation and blood doping. , 2013, Blood transfusion = Trasfusione del sangue.
[127] R. Holt,et al. Detecting growth hormone abuse in athletes , 2011, Analytical and bioanalytical chemistry.
[128] V. Backer,et al. The Pharmacokinetic Profile of Inhaled and Oral Salbutamol in Elite Athletes With Asthma and Nonasthmatic Subjects , 2012, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[129] M. Thevis,et al. Liquid Chromatography-High Resolution/High Accuracy (Tandem) Mass Spectrometry-Based Identification of in vivo Generated Metabolites of the Selective Androgen Receptor Modulator ACP-105 for Doping Control Purposes , 2014, European journal of mass spectrometry.
[130] A. Lesiak,et al. DART-MS for rapid, preliminary screening of urine for DMAA. , 2014, Drug testing and analysis.
[131] K. Ho,et al. Growth Hormone in Sports: Detecting the Doped or Duped , 2011, Hormone Research in Paediatrics.
[132] Gongke Li,et al. A novel protocol for molecularly imprinted polymer filaments online coupled to GC-MS for the determination of androgenic steroids in urine. , 2013, Journal of separation science.
[133] A. Kniess,et al. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports. , 2013, Journal of pharmaceutical and biomedical analysis.
[134] C. Gore,et al. Detraining Decreases Hbmass of Triathletes , 2012, International Journal of Sports Medicine.
[135] Ó. Pozo,et al. Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis. , 2013, Bioanalysis.
[136] N. Baume,et al. SARM-S4 and metabolites detection in sports drug testing: a case report. , 2011, Forensic science international.
[137] Christopher R Harrison,et al. Towards the identification of autologous blood transfusions through capillary electrophoresis , 2013, Analytical and Bioanalytical Chemistry.
[138] Andrew T Kicman,et al. Biochemical and physiological aspects of endogenous androgens. , 2010, Handbook of experimental pharmacology.
[139] G. Leroux-Roels,et al. Metabolic studies with promagnon, methylclostebol and methasterone in the uPA+/+-SCID chimeric mice , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[140] R. Dierckx,et al. Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging , 2012, European journal of clinical investigation.
[141] D. Andreu,et al. Alterations of the erythrocyte membrane proteome and cytoskeleton network during storage--a possible tool to identify autologous blood transfusion. , 2012, Drug testing and analysis.
[142] M. Thevis,et al. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. , 2015, Drug testing and analysis.
[143] K. Ho,et al. Growth hormone administration: is it safe and effective for athletic performance. , 2010, Endocrinology and metabolism clinics of North America.
[144] E. Callaway. Sports doping: Racing just to keep up , 2011, Nature.
[145] F. S. Rojas,et al. Recent developments in analytical determination of furosemide. , 2008 .
[146] Elliot R. Cooper,et al. In Vitro Androgen Bioassays as a Detection Method for Designer Androgens , 2013, Sensors.
[147] R. Plumb,et al. Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the quantification of ephedrines using medium-resolution accurate mass spectrometry. , 2013, Journal of chromatography. A.
[148] M. Thevis,et al. Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing. , 2013, Rapid communications in mass spectrometry : RCM.
[149] J. Wuestenfeld,et al. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes. , 2010, Endocrinology and metabolism clinics of North America.
[150] M. Mascini,et al. Simultaneous detection of transgenic DNA by surface plasmon resonance imaging with potential application to gene doping detection. , 2011, Analytical chemistry.
[151] S. Rzeppa,et al. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry. , 2015, Drug testing and analysis.
[152] M. Hsu,et al. Determination of raloxifene in urine by liquid chromatography-tandem mass spectrometry for doping. , 2013, Journal of analytical toxicology.
[153] M. Thevis,et al. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer , 2012, Analytical and Bioanalytical Chemistry.
[154] T. Friedmann,et al. Gene Doping and Sport , 2010, Science.
[155] Yasuhiko Takahashi,et al. A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate. , 2013, European journal of pharmacology.
[156] Nathalie A. Desrosiers,et al. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? , 2014, Clinical chemistry.
[157] U. Flenker. Isotope ratio mass spectrometry - history and terminology in brief. , 2012, Drug testing and analysis.
[158] H. Peyrière,et al. Misuse of anabolic products in sport: a retrospective study of phone calls at the Écoute Dopage anti-doping hot-line. , 2013, Therapie.
[159] R. Ventura,et al. Determination of five di-(2-ethylhexyl)phthalate metabolites in urine by UPLC-MS/MS, markers of blood transfusion misuse in sports. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[160] M. Nielen,et al. Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres , 2013, Analytical and Bioanalytical Chemistry.
[161] H. Lieberman,et al. Analysis of 1,3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements. , 2014, Drug testing and analysis.
[162] J. Schulze,et al. The Impact of Genetics and Hormonal Contraceptives on the Steroid Profile in Female Athletes , 2014, Front. Endocrinol..
[163] E. Virus,et al. 'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry. , 2012, Journal of mass spectrometry : JMS.
[164] J. Pinkstaff,et al. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin. , 2013, Journal of immunological methods.
[165] M. Thevis,et al. Application of FAIMS to anabolic androgenic steroids in sport drug testing. , 2009, Drug testing and analysis.
[166] K. Carlsen,et al. Exercise and asthma: an overview , 2015, European clinical respiratory journal.
[167] L. Delgado,et al. Impact of Changes in Anti-doping Regulations (WADA Guidelines) on Asthma Care in Athletes , 2013, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[168] M. Thevis. Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays , 2010 .
[169] David Handelsman,et al. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men , 2009, Clinical endocrinology.
[170] M. Thevis,et al. Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation. , 2012, Journal of pharmaceutical and biomedical analysis.
[171] M. Thevis,et al. Doping control analysis of trenbolone and related compounds using liquid chromatography–tandem mass spectrometry , 2009, Steroids.
[172] U. Mareck,et al. 13C/12C ratios of endogenous urinary steroids investigated for doping control purposes. , 2009, Drug testing and analysis.
[173] R. Roškar,et al. Determination of raloxifene and its glucuronides in human urine by liquid chromatography-tandem mass spectrometry assay. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[174] J. Schulze,et al. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. , 2008, The Journal of clinical endocrinology and metabolism.
[175] K. Deventer,et al. Doping control analysis of desmopressin in human urine by LC-ESI-MS/MS after urine delipidation. , 2013, Biomedical chromatography : BMC.
[176] M. Thevis,et al. Mass spectrometric detection of peginesatide in human urine in doping control analysis. , 2012, Journal of pharmaceutical and biomedical analysis.
[177] Monica Mazzarino,et al. Screening and confirmation analysis of stimulants, narcotics and beta-adrenergic agents in human urine by hydrophilic interaction liquid chromatography coupled to mass spectrometry. , 2011, Journal of chromatography. A.
[178] G. Vollmer,et al. Detection of anabolic steroid abuse using a yeast transactivation system , 2008, Steroids.
[179] J. Simmchen,et al. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios. , 2011, Drug testing and analysis.
[180] M. Saugy,et al. Recent developments in the use of isotope ratio mass spectrometry in sports drug testing , 2011, Analytical and bioanalytical chemistry.
[181] C. Reichel. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion. , 2012, Drug testing and analysis.
[182] F. Botrè,et al. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[183] E Eryl Bassett,et al. Statistical issues in implementing the marker method. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[184] P. Dou,et al. Immuno-magnetic beads-based extraction-capillary zone electrophoresis-deep UV laser-induced fluorescence analysis of erythropoietin. , 2012, Journal of chromatography. A.
[185] J. Baker,et al. Potential benefits of recombinant human growth hormone (rhGH) to athletes. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[186] J. Kopchick,et al. Perspective: proteomic approach to detect biomarkers of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[187] F. Gosetti,et al. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[188] M. Thevis,et al. Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. , 2011, Drug testing and analysis.
[189] M. Thevis,et al. Mass spectrometry-based analysis of IGF-1 and hGH. , 2010, Handbook of experimental pharmacology.
[190] IEF pattern classification‐derived criteria for the identification of epoetin‐δ in urine , 2010, Electrophoresis.
[191] M. Duclos. Glucocorticoids: a doping agent? , 2010, Endocrinology and metabolism clinics of North America.
[192] Martial Saugy,et al. Circulating miRNAs: a new generation of anti-doping biomarkers , 2013, Analytical and Bioanalytical Chemistry.
[193] H. Geyer,et al. Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes , 2010, Steroids.
[194] P. Simon,et al. Detection of EPO gene doping in blood. , 2012, Drug testing and analysis.
[195] M. Thevis,et al. Quantification of urinary AICAR concentrations as a matter of doping controls , 2010, Analytical and bioanalytical chemistry.
[196] P. Sönksen,et al. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[197] M. Thevis,et al. Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testing. , 2012, Drug testing and analysis.
[198] M. Thevis,et al. RNA interference for performance enhancement and detection in doping control. , 2011, Drug testing and analysis.
[199] M. Thevis,et al. Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing , 2012, Analytical and Bioanalytical Chemistry.
[200] R. Robergs,et al. Identifying plasma glycerol concentration associated with urinary glycerol excretion in trained humans. , 2011, Journal of analytical toxicology.
[201] Erin E. Chambers,et al. Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma. , 2014, Analytical chemistry.
[202] J. Hale,et al. Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia , 2010, Expert opinion on therapeutic patents.
[203] Y. Angelis,et al. Current status and recent advantages in derivatization procedures in human doping control. , 2015, Bioanalysis.
[204] P. Sönksen,et al. The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes. , 2010, European journal of endocrinology.
[205] R. L. Hilderbrand. High-performance sport, marijuana, and cannabimimetics. , 2011, Journal of analytical toxicology.
[206] N. Robinson,et al. Procedures for monitoring recombinant erythropoietin and analogs in doping. , 2010, Endocrinology and metabolism clinics of North America.
[207] Irene C. Perez,et al. PCR-based detection of gene transfer vectors: application to gene doping surveillance , 2013, Analytical and Bioanalytical Chemistry.
[208] G. Jacobson,et al. Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle. , 2014, Drug testing and analysis.
[209] Weiling Fu,et al. rhEPO/EPO discrimination with ultrasensitive electrochemical biosensor based on sandwich-type nano-Au/ZnO sol-gel/nano-Au signal amplification. , 2013, Biosensors & bioelectronics.
[210] H. Geyer,et al. Detection of Δ6-methyltestosterone in a "dietary supplement" and GC-MS/MS investigations on its urinary metabolism. , 2011, Toxicology letters.
[211] W. Jelkmann,et al. Intolerability of cobalt salt as erythropoietic agent. , 2014, Drug testing and analysis.
[212] M. Thevis,et al. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. , 2013, Drug testing and analysis.
[213] G. Lippi,et al. Improvement in sprint performance: doping or nature? , 2013, Drug testing and analysis.
[214] M. Bidlingmaier. New detection methods of growth hormone and growth factors. , 2012, Endocrine development.
[215] Y. Goda,et al. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. , 2010, Forensic science international.
[216] Martial Saugy,et al. Prevalence of blood doping in samples collected from elite track and field athletes. , 2011, Clinical chemistry.
[217] A. E. Lima-Silva,et al. Impaired Physical Performance and Clinical Responses after a Recreational Bodybuilder's Self-Administration of Steroids: A Case Report , 2015, The world journal of men's health.
[218] Kuei-Hui Chan,et al. Urinary elimination of ephedrines following administration of the Traditional Chinese Medicine preparation Kakkon-to. , 2008, Journal of analytical toxicology.
[219] J. Lademann,et al. Optical Coherent Tomography for in vivo Determination of Changes in Hair Cross Section and Diameter during Treatment with Glucocorticosteroids – A Simple Method to Screen for Doping Substances? , 2008, Skin Pharmacology and Physiology.
[220] D. Armstrong,et al. 1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? , 2012, Drug testing and analysis.
[221] J. Dvořák,et al. Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts , 2012, British Journal of Sports Medicine.
[222] G. Gmeiner,et al. Screening of testosterone esters in human plasma. , 2013, Drug testing and analysis.
[223] V. Backer,et al. Combined inhalation of beta2‐agonists improves swim ergometer sprint performance but not high‐intensity swim performance , 2014, Scandinavian journal of medicine & science in sports.
[224] M. Farré,et al. Urinary metabolic profile of 19-norsteroids in humans: glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol. , 2008, Rapid communications in mass spectrometry : RCM.
[225] J. Schulze,et al. Non-Steroidal Anti-Inflammatory Drugs Do Not Influence the Urinary Testosterone/Epitestosterone Glucuronide Ratio , 2013, Front. Endocrinol..
[226] P. Eenoo,et al. Development of a GC/C/IRMS method – Confirmation of a novel steroid profiling approach in doping control , 2012, Steroids.
[227] J. Christiansen,et al. Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections ☆ ☆☆ ★: Implications for detection of GH abuse , 2010 .
[228] F. Botrè,et al. A simplified procedure for GC/C/IRMS analysis of underivatized 19-norandrosterone in urine following HPLC purification , 2011, Steroids.
[229] F. A. Neto,et al. Screening for hydroxyethyl starch (HES) doping in sport. , 2010, Journal of science and medicine in sport.
[230] M. Ashenden,et al. Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments , 2012, Journal of Clinical Pathology.
[231] C. Georgakopoulos,et al. External calibration in gas chromatography-combustion-isotope ratio mass spectrometry measurements of endogenous androgenic anabolic steroids in sports doping control. , 2011, Journal of chromatography. A.
[232] P. O'Malley. The drive to win and never grow old: the risks of anabolic steroid abuse, an update for the clinical nurse specialist. , 2013, Clinical nurse specialist CNS.
[233] D. Bruns,et al. Circulating microRNA as a biomarker of human growth hormone administration to patients. , 2014, Drug testing and analysis.
[234] Ó. Pozo,et al. Sensitive and robust method for anabolic agents in human urine by gas chromatography-triple quadrupole mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[235] V. Lopez-Avila,et al. Identification of methylhexaneamine by GC high-resolution TOFMS and soft ionization. , 2013, Forensic science international.
[236] C. Gore,et al. Stability of athlete passport parameters during extended storage , 2013, International journal of laboratory hematology.
[237] Ó. Pozo,et al. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis. , 2012, Drug testing and analysis.
[238] R. Kostiainen,et al. Analysis of anabolic steroids in urine by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry with chlorobenzene as dopant. , 2013, Journal of chromatography. A.
[239] M. Saugy,et al. A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. , 2011, Forensic science international.
[240] S. Han,et al. Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS. , 2012, Journal of pharmaceutical and biomedical analysis.
[241] N. Baume,et al. Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. A.
[242] A. Petróczi,et al. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids , 2010, Substance abuse treatment, prevention, and policy.
[243] C. Lundby,et al. Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations? , 2009, European Journal of Applied Physiology.
[244] L. James,et al. Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. , 2013, Analytical chemistry.
[245] X. de la Torre,et al. A comprehensive procedure based on gas chromatography-isotope ratio mass spectrometry following high performance liquid chromatography purification for the analysis of underivatized testosterone and its analogues in human urine. , 2012, Analytica chimica acta.
[246] Jordi Segura,et al. Current strategic approaches for the detection of blood doping practices. , 2011, Forensic science international.
[247] V. Backer,et al. High‐dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men , 2012, Scandinavian journal of medicine & science in sports.
[248] Martial Saugy,et al. The athlete biological passport. , 2011, Clinical chemistry.
[249] A. George,et al. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control. , 2009, Drug testing and analysis.
[250] M. Saugy,et al. Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept. , 2012, Drug testing and analysis.
[251] W. Schänzer,et al. Sports-related issues and biochemistry of natural and synthetic anabolic substances. , 2010, Endocrinology and metabolism clinics of North America.
[252] L. Reubsaet,et al. Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis. , 2013, Bioanalysis.
[253] J. Kelly,et al. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. , 2011, Drug testing and analysis.
[254] M. Rondon,et al. Impaired Post Exercise Heart Rate Recovery in Anabolic Steroid Users , 2013, International Journal of Sports Medicine.
[255] M. Pfaffl,et al. The analysis of the transcriptome as a new approach for biomarker development to trace the abuse of anabolic steroid hormones. , 2011, Drug testing and analysis.
[256] M. Thevis,et al. Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes. , 2009, Rapid communications in mass spectrometry : RCM.
[257] B. Sporer,et al. Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists , 2013, British Journal of Sports Medicine.
[258] M. Thevis,et al. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators. , 2010, Handbook of experimental pharmacology.
[259] D. Catlin,et al. Enrichment and immunoprecipitation of 22 kDa human growth hormone spiked into human urine. , 2009, Drug testing and analysis.
[260] A. Cawley. Stable isotope ratio analysis in sports anti-doping. , 2012, Drug testing and analysis.
[261] R. Donovan,et al. Young athletes' awareness and monitoring of anti‐doping in daily life: Does motivation matter? , 2015, Scandinavian journal of medicine & science in sports.
[262] W. Schänzer,et al. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates. , 2012, Drug testing and analysis.
[263] C. Reichel. OMICS-strategies and methods in the fight against doping. , 2011, Forensic science international.
[264] A. Butch,et al. Genetic variations in UDP-glucuronosyl transferase 2B17: implications for testosterone excretion profiling and doping control programs. , 2008, Clinical chemistry.
[265] K. Langohr,et al. Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples. , 2010, Journal of pharmaceutical and biomedical analysis.
[266] T. Haahtela,et al. Asthma Medication Is Increasingly Prescribed for Finnish Olympic Athletes—For a Reason? , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.
[267] J. Tabet,et al. Urine ratio of tetrahydrocortisol to tetrahydrodeoxycortisol to screen for the systemic administration of cortisone and hydrocortisone. , 2009, Forensic science international.
[268] Guonan Chen,et al. Determination of diuretics in human urine by hollow fiber-based liquid-liquid-liquid microextraction coupled to high performance liquid chromatography. , 2008, The Analyst.
[269] C. Reichel,et al. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. , 2009, Drug testing and analysis.
[270] B. Venhuis,et al. A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. , 2014, Drug testing and analysis.
[271] W. Young,et al. Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping. , 2008, Exercise immunology review.
[272] M. Thevis,et al. Urinary excretion of exogenous glycerol administration at rest. , 2011, Drug testing and analysis.
[273] M. Mazzarino,et al. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies , 2013, Analytical and Bioanalytical Chemistry.
[274] V. Backer,et al. Asthma in elite athletes , 2011, Expert review of respiratory medicine.
[275] S. Theocharis,et al. Doping and musculoskeletal system: short‐term and long‐lasting effects of doping agents , 2011, Fundamental & clinical pharmacology.
[276] M. Thevis,et al. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach. , 2011, Drug testing and analysis.
[277] M. Koller,et al. Carbon isotope ratio determination and investigation of seized testosterone preparations. , 2011, Drug testing and analysis.
[278] K. High,et al. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges , 2011, Nature Reviews Genetics.
[279] M. Marco,et al. Multiplexed immunoassay to detect anabolic androgenic steroids in human serum , 2012, Analytical and Bioanalytical Chemistry.
[280] A. George,et al. Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping. , 2012, Drug testing and analysis.
[281] F. Lasne. Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. , 2015, Methods in molecular biology.
[282] G. De Paoli,et al. Naphyrone: analytical profile of the new "legal high" substitute for mephedrone. , 2011, Journal of forensic and legal medicine.
[283] J. Capelo,et al. Accelerated sample treatment for screening of banned doping substances by GC–MS: ultrasonication versus microwave energy , 2011, Analytical and bioanalytical chemistry.
[284] O. Rabin,et al. Investigating the use of stimulants in out-of-competition sport samples. , 2011, Journal of analytical toxicology.
[285] M. Thevis,et al. Metabolism of human insulin after subcutaneous administration: A possible means to uncover insulin misuse. , 2015, Analytica chimica acta.
[286] M. Thevis,et al. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. , 2012, Journal of chromatography. A.
[287] R. Holt. Is human growth hormone an ergogenic aid? , 2009, Drug testing and analysis.
[288] T. Rosén,et al. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health , 2013, British Journal of Sports Medicine.
[289] W. Schänzer,et al. CYP21-catalyzed production of the long-term urinary metandienone metabolite 17β-hydroxymethyl-17α-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping , 2010, Biological chemistry.
[290] R. Ventura,et al. Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletes. , 2009, Journal of pharmaceutical and biomedical analysis.
[291] Ó. Pozo,et al. uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study. , 2009, Clinical chemistry.
[292] R. Baxter,et al. Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[293] N. Robinson,et al. Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse. , 2011, Drug testing and analysis.
[294] Moutian Wu,et al. Detection of clenbuterol at trace levels in doping analysis using different gas chromatographic-mass spectrometric techniques. , 2013, Journal of chromatographic science.
[295] J. Carlsson,et al. Rapid detection of erythropoiesis-stimulating agents in urine and serum. , 2012, Analytical biochemistry.
[296] M. Thevis,et al. Proteolysis and autolysis of proteases and the detection of degradation products in doping control. , 2009, Drug testing and analysis.
[297] A. Beotra,et al. Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons. , 2009, Drug testing and analysis.
[298] M. Thevis,et al. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing , 2011, Analytical and bioanalytical chemistry.
[299] Kuei-Hui Chan,et al. Oxethazaine as the source of mephentermine and phentermine in athlete's urine. , 2009, Forensic science international.
[300] Ó. Pozo,et al. Quantitative Detection of Inhaled Salmeterol in Human Urine and Relevance to Doping Control Analysis , 2011, Therapeutic drug monitoring.
[301] M. Gütschow,et al. Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS. , 2009, Drug testing and analysis.
[302] H. Yoo,et al. Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC‐MS/MS , 2013, Journal of forensic sciences.
[303] E. Virus,et al. Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine. , 2012, Drug testing and analysis.
[304] C. Fernández-Pérez,et al. Impact of UGT2B17 gene deletion on the steroid profile of an athlete , 2015, Physiological reports.
[305] M. Cowley,et al. Detection of growth hormone doping by gene expression profiling of peripheral blood. , 2009, The Journal of clinical endocrinology and metabolism.
[306] C. Lundby,et al. Novel serum biomarkers for erythropoietin use in humans: a proteomic approach. , 2011, Journal of applied physiology.
[307] P. Sönksen,et al. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport. , 2010, The Journal of clinical endocrinology and metabolism.
[308] G. Bouguen,et al. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers , 2011, European Journal of Applied Physiology.
[309] D. Kwiatkowska,et al. Problems of the Use of Pseudoephedrine by Athletes , 2009, International journal of sports medicine.
[310] H. Schwarzenbach. Impact of physical activity and doping on epigenetic gene regulation. , 2011, Drug testing and analysis.
[311] A. Petróczi,et al. Analysis of anabolic steroids in human hair using LC–MS/MS , 2010, Steroids.
[312] L Avois,et al. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis. , 2009, Journal of chromatography. A.
[313] P. Eenoo,et al. Profiling of urinary formestane and confirmation by isotope ratio mass spectrometry , 2013, Steroids.
[314] M. Thevis,et al. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. , 2015, Drug testing and analysis.
[315] A. Casilli,et al. Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option. , 2009, Journal of chromatography. A.
[316] C. Reichel,et al. SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. , 2009, Drug testing and analysis.
[317] A. George,et al. The detection of androstenedione abuse in sport: a mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite. , 2008, Rapid communications in mass spectrometry : RCM.
[318] David Handelsman,et al. Immunoreactive LH in long-term frozen human urine samples. , 2014, Drug testing and analysis.
[319] A. Bergmann,et al. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. , 2009, Clinical chemistry.
[320] R. Heltsley,et al. Prevalence of synthetic cannabinoids in U.S. athletes: initial findings. , 2012, Journal of analytical toxicology.
[321] M. Thevis,et al. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. , 2010, Drug testing and analysis.
[322] X. de la Torre,et al. Rapid screening of beta-adrenergic agents and related compounds in human urine for anti-doping purpose using capillary electrophoresis with dynamic coating. , 2009, Journal of separation science.
[323] P. Lantéri,et al. Data-handling strategies for metabonomic studies: example of the UHPLC-ESI/ToF urinary signature of tetrahydrocannabinol in humans , 2014, Analytical and Bioanalytical Chemistry.
[324] A. Prakash,et al. Targeted Selected Reaction Monitoring Mass Spectrometric Immunoassay for Insulin-like Growth Factor 1 , 2013, PloS one.
[325] Patricia L. Ranaivo,et al. Analysis and Confirmation of 1,3-DMAA and 1,4-DMAA in Geranium Plants Using High Performance Liquid Chromatography with Tandem Mass Spectrometry at ng/g Concentrations , 2012, Analytical chemistry insights.
[326] Ó. Pozo,et al. Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. , 2009, Journal of chromatography. A.
[327] M. Thevis,et al. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105. , 2013, Rapid communications in mass spectrometry : RCM.
[328] Wilhelm Schänzer,et al. Current role of LC-MS(/MS) in doping control , 2007, Analytical and bioanalytical chemistry.
[329] J. Dvořák,et al. Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. , 2013, Drug testing and analysis.
[330] E. Mayatepek,et al. Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse , 2013, Journal of pediatric endocrinology & metabolism : JPEM.
[331] Bu Hz,et al. A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment. , 2006 .
[332] Ó. Pozo,et al. Urinary profile of methylprednisolone and its metabolites after oral and topical administrations , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[333] D. Barceloux,et al. Anabolic-androgenic steroids. , 2013, Disease-a-month : DM.
[334] W. Hopkins,et al. Variability of Serum Markers of Erythropoiesis during 6 Days of Racing in Highly Trained Cyclists , 2013, International Journal of Sports Medicine.
[335] Beverly L. Davidson,et al. Current prospects for RNA interference-based therapies , 2011, Nature Reviews Genetics.
[336] J. Coombes,et al. Performance benefits of rehydration with intravenous fluid and oral glycerol. , 2012, Medicine and science in sports and exercise.
[337] M. Thevis,et al. Stimulants and doping in sport. , 2010, Endocrinology and metabolism clinics of North America.
[338] X. de la Torre,et al. Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[339] P. Marriott,et al. Application of comprehensive two-dimensional gas chromatography to sterols analysis. , 2008, Journal of chromatography. A.
[340] A. Ouellet,et al. A simplified and accurate method for the analysis of urinary metabolites of testosterone-related steroids using gas chromatography/combustion/isotope ratio mass spectrometry. , 2013, Rapid communications in mass spectrometry : RCM.
[341] Irene van den Broek,et al. Current trends in mass spectrometry of peptides and proteins: Application to veterinary and sports-doping control. , 2015, Mass spectrometry reviews.
[342] Ying Dong,et al. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes. , 2011, The Analyst.
[343] K. Deventer,et al. Specific screening method for dextran and hydroxyethyl starch in human urine by size exclusion chromatography–in-source collision-induced dissociation–time-of-flight mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[344] Toyoki Mori,et al. Bronchodilating Effect and Anabolic Effect of Inhaled Procaterol , 2008, International journal of sports medicine.
[345] Stefan E Franz,et al. Erythropoiesis-stimulating agents: development, detection and dangers. , 2009, Drug testing and analysis.
[346] D. Gould. Gene doping: gene delivery for olympic victory , 2013, British journal of clinical pharmacology.
[347] D. Cowan,et al. Doping in sport—2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisterone , 2009, Steroids.
[348] D. Volmer,et al. Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection. , 2012, Drug testing and analysis.
[349] Aaron C. T. Smith,et al. Why the war on drugs in sport will never be won , 2015, Harm Reduction Journal.
[350] N. Robinson,et al. The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports. , 2013, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[351] P. Sönksen,et al. Influence of ethnicity on IGF‐I and procollagen III peptide (P‐III‐P) in elite athletes and its effect on the ability to detect GH abuse , 2009, Clinical endocrinology.
[352] M. Parr,et al. Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system , 2011, Archives of Toxicology.
[353] P. Sottas,et al. Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport? , 2010, International journal of laboratory hematology.
[354] C. Cren-olivé,et al. Comparison of the analysis of beta-blockers by different techniques. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[355] M. Thevis,et al. Meta-analysis: Effects of glycerol administration on plasma volume, haemoglobin, and haematocrit. , 2013, Drug testing and analysis.
[356] A. Garnham,et al. Current markers of the Athlete Blood Passport do not flag microdose EPO doping , 2011, European Journal of Applied Physiology.
[357] C. Ayotte. Detecting the administration of endogenous anabolic androgenic steroids. , 2010, Handbook of experimental pharmacology.
[358] X. de la Torre,et al. Speeding up the process urine sample pre-treatment: some perspectives on the use of microwave assisted extraction in the anti-doping field. , 2010, Talanta.
[359] S. Rennard,et al. PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease , 2012, Clinical pharmacology and therapeutics.
[360] T. Friedmann. How Close Are We to Gene Doping? , 2010, The Hastings Center report.
[361] M. Thevis,et al. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. , 2013, Bioanalysis.
[362] T. McDade. Development and validation of assay protocols for use with dried blood spot samples , 2014, American journal of human biology : the official journal of the Human Biology Council.
[363] I. McGregor,et al. Exercise increases plasma THC concentrations in regular cannabis users. , 2013, Drug and alcohol dependence.
[364] M. Thevis,et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. , 2011, Drug testing and analysis.
[365] A. Brailsford,et al. Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control. , 2012, Drug testing and analysis.
[366] Keita Saito,et al. Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. , 2010, Journal of pharmaceutical and biomedical analysis.
[367] D. Poirier,et al. Characterization of desoxymethyltestosterone main urinary metabolite produced from cultures of human fresh hepatocytes , 2012, Steroids.
[368] Y. Dehnes,et al. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections. , 2013, Drug testing and analysis.
[369] S. Hahner,et al. Dehydroepiandrosterone to enhance physical performance: myth and reality. , 2010, Endocrinology and metabolism clinics of North America.
[370] R. Bloomer,et al. Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men , 2013, Human & experimental toxicology.
[371] H. Sumnall,et al. Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. , 2011, Drug testing and analysis.
[372] D. Catlin,et al. The Influence of Diet on Isotope Ratio Mass Spectrometry Values , 2009, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[373] K. Deventer,et al. Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. , 2012, Analytica chimica acta.
[374] K. Deventer,et al. Qualitative detection of desmopressin in plasma by liquid chromatography–tandem mass spectrometry , 2012, Analytical and Bioanalytical Chemistry.
[375] J. Auwerx,et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.
[376] D. Eichner,et al. A population study of urine glycerol concentrations in elite athletes competing in North America. , 2013, Drug testing and analysis.
[377] Ilkka Ojanperä,et al. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control , 2012, Analytical and Bioanalytical Chemistry.
[378] K. Haupt,et al. Toward the use of a molecularly imprinted polymer in doping analysis: selective preconcentration and analysis of testosterone and epitestosterone in human urine. , 2010, Analytical chemistry.
[379] H. Maurer,et al. Identification and differentiation of beta-blockers and their metabolites in urine by computerized gas chromatography-mass spectrometry. , 1986, Journal of chromatography.
[380] S. Kageyama,et al. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application. , 2011, Drug testing and analysis.
[381] Osquel Barroso,et al. Detection of GH abuse in sport: Past, present and future. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[382] M. Giacca,et al. Enhanced athletic performance on multisite AAV-IGF1 gene transfer coincides with massive modification of the muscle proteome. , 2012, Human gene therapy.
[383] B. Sellergren,et al. Glucuronide directed molecularly imprinted solid-phase extraction: isolation of testosterone glucuronide from its parent drug in urine. , 2012, The Analyst.
[384] M. Buemi,et al. Does erythropoietin always win? , 2014, Current medicinal chemistry.
[385] D. Cowan,et al. Laboratory issues in the implementation of the marker method. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[386] K. Deventer,et al. Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine. , 2012, Journal of pharmaceutical and biomedical analysis.
[387] M. Saugy,et al. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing , 2013, Analytical and Bioanalytical Chemistry.
[388] M. Koupparis,et al. Stabilization of human urine doping control samples: a current opinion , 2011, Analytical and bioanalytical chemistry.
[389] A. Petróczi,et al. Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation , 2012, Steroids.
[390] U. Flenker,et al. The application of carbon isotope ratio mass spectrometry to doping control. , 2008, Journal of mass spectrometry : JMS.
[391] M. Thevis,et al. Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing , 2011, Analytical and bioanalytical chemistry.
[392] M. Huestis,et al. Cannabis in Sport , 2011, Sports medicine.
[393] D. Eichner,et al. Detection of human insulin-like growth factor-1 in deer antler velvet supplements. , 2013, Rapid communications in mass spectrometry : RCM.
[394] M. Thevis,et al. Annual banned-substance review: analytical approaches in human sports drug testing. , 2012, Drug testing and analysis.
[395] L. Ekström,et al. Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[396] M. Thevis,et al. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis. , 2009, Journal of mass spectrometry : JMS.
[397] R. Gutiérrez-Gallego,et al. Purification of erythropoietin from human plasma samples using an immunoaffinity well plate. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[398] Giuseppe Banfi,et al. Limits and pitfalls of Athlete's Biological Passport , 2011, Clinical chemistry and laboratory medicine.
[399] A. Deligiannis,et al. Cardiovascular adverse effects of doping in sports. , 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[400] Fabian Sanchis-Gomar,et al. Current limitations of the Athlete's Biological Passport use in sports , 2011, Clinical chemistry and laboratory medicine.
[401] J. V. Sancho,et al. Comparison between triple quadrupole, time of flight and hybrid quadrupole time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. , 2011, Analytica chimica acta.
[402] Determining the authenticity of athlete urine in doping control by DNA analysis. , 2015, Drug testing and analysis.
[403] A. Baoutina,et al. Improved detection of transgene and nonviral vectors in blood. , 2013, Human gene therapy methods.
[404] H. Tobias,et al. Comprehensive 2-dimensional gas chromatography fast quadrupole mass spectrometry (GC × GC-qMS) for urinary steroid profiling: mass spectral characteristics with chemical ionization. , 2011, Drug testing and analysis.
[405] Fong-Ha Liu,et al. Certification of steroid carbon isotope ratios in a freeze-dried human urine reference material. , 2012, Drug testing and analysis.
[406] Helen Thompson. Performance enhancement: Superhuman athletes , 2012, Nature.
[407] H. Toriello,et al. Gene doping: the hype and the harm. , 2010, Pediatric clinics of North America.
[408] Ó. Pozo,et al. Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[409] P. Hemmersbach,et al. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters. , 2011, Drug testing and analysis.
[410] Monica Mazzarino,et al. Microwave irradiation for a fast gas chromatography-mass spectrometric analysis of polysaccharide-based plasma volume expanders in human urine. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[411] M. Geraci,et al. New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder , 2011, Human & experimental toxicology.
[412] Ó. Pozo,et al. Ultra high performance liquid chromatography tandem mass spectrometric detection of glucuronides resistant to enzymatic hydrolysis: Implications to doping control analysis. , 2015, Analytica chimica acta.
[413] Lisi Zhang,et al. Biomarker detection of rhGH doping: an excretion study. , 2012, Drug testing and analysis.
[414] Serge Rudaz,et al. A steroidomic approach for biomarkers discovery in doping control. , 2011, Forensic science international.
[415] J. Schulze,et al. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests , 2009, Steroids.
[416] A. Rogol. Drugs of abuse and the adolescent athlete , 2010, Italian journal of pediatrics.
[417] J. Ramsey,et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. , 2010, Journal of analytical toxicology.
[418] Kuei-Hui Chan,et al. Elimination of ephedrines in urine following administration of a Sho-seiryu-to preparation. , 2009, Journal of analytical toxicology.
[419] M. Huestis,et al. Current knowledge on cannabinoids in oral fluid. , 2014, Drug testing and analysis.
[420] H. Geyer,et al. Determination of (13)C/(12)C ratios of urinary excreted boldenone and its main metabolite 5beta-androst-1-en-17beta-ol-3-one. , 2010, Drug testing and analysis.
[421] Ó. Pozo,et al. Use of LC-MS/MS for the open detection of steroid metabolites conjugated with glucuronic acid. , 2013, Analytical chemistry.
[422] A. Butch,et al. Carbon isotope ratio mass spectrometry for detection of endogenous steroid use: a testing strategy. , 2013, Drug testing and analysis.
[423] X. de la Torre,et al. Reference ranges for the urinary steroid profile in a Latin-American population. , 2013, Drug testing and analysis.
[424] Wilhelm Schänzer,et al. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. , 2009, Drug testing and analysis.
[425] M. Mazzarino,et al. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: Endogenous steroids urinary profile after multiple oral doses , 2011, Steroids.
[426] J. Mazanov. Beyond antidoping and harm minimisation: a stakeholder-corporate social responsibility approach to drug control for sport , 2015, Journal of Medical Ethics.
[427] H. Yoo,et al. Simple and accurate quantitative analysis of seven prohibited threshold substances in human urine by liquid chromatography/tandem mass spectrometry in doping control. , 2011, Rapid communications in mass spectrometry : RCM.
[428] S. Kageyama,et al. Determination of mepitiostane metabolites in human urine by liquid chromatography/tandem mass spectrometry for sports drug testing. , 2015, Journal of pharmaceutical and biomedical analysis.
[429] B. Wuyam,et al. Effect of salbutamol on neuromuscular function in endurance athletes. , 2013, Medicine and science in sports and exercise.
[430] Sébastien Anizan,et al. The potential role of oral fluid in antidoping testing. , 2014, Clinical chemistry.
[431] M. Thevis,et al. Targeting prohibited substances in doping control blood samples by means of chromatographic–mass spectrometric methods , 2013, Analytical and Bioanalytical Chemistry.
[432] V. Backer,et al. Urine and Serum Concentrations of Inhaled and Oral Terbutaline , 2012, International Journal of Sports Medicine.
[433] P. Dargan,et al. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone , 2010, Emergency Medicine Journal.
[434] M. Thevis,et al. Investigations of the microbial transformation of cortisol to prednisolone in urine samples , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[435] G. Goldspink,et al. Growth factors, muscle function, and doping. , 2010, Endocrinology and metabolism clinics of North America.
[436] V. Backer,et al. Urine Concentrations of Repetitive Doses of Inhaled Salbutamol , 2011, International journal of sports medicine.
[437] Richard R Young,et al. Overview of the legal framework applicable to the marker method for the detection of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[438] V. Backer,et al. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations. , 2013, Medicine and science in sports and exercise.
[439] N. Baume,et al. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. , 2011, Analytica chimica acta.
[440] C. Lundby,et al. Detection of EPO injections using a rapid lateral flow isoform test , 2013, Analytical and Bioanalytical Chemistry.
[441] Charlotte Bell,et al. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. , 2011, Drug testing and analysis.
[442] B. Saltin,et al. The evolving science of detection of ‘blood doping’ , 2012, British journal of pharmacology.
[443] Martial Saugy,et al. Statistical discrimination of steroid profiles in doping control with support vector machines. , 2013, Analytica chimica acta.
[444] Hazel Torrance,et al. The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. , 2010, Forensic science international.
[445] P. Sönksen,et al. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays. , 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[446] M. Thevis,et al. Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. , 2013, Rapid communications in mass spectrometry : RCM.
[447] S. Kageyama,et al. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.
[448] P. Simon,et al. Principle considerations for the use of transcriptomics in doping research. , 2011, Drug testing and analysis.
[449] W. Ni,et al. Development and Utility of an Internal Threshold Control (ITC) Real-Time PCR Assay for Exogenous DNA Detection , 2012, PloS one.
[450] Giuseppe Lippi,et al. Preanalytical variability: the dark side of the moon in blood doping screening , 2010, European Journal of Applied Physiology.
[451] M. Thevis,et al. Storage‐induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high‐resolution/high‐accuracy MS , 2012, Proteomics.
[452] K. Deventer,et al. Prevalence of legal and illegal stimulating agents in sports , 2011, Analytical and bioanalytical chemistry.
[453] H. Geyer,et al. Seized designer supplement named “1-Androsterone”: Identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination , 2011, Steroids.
[454] R. Plumb,et al. A simple high pH liquid chromatography-tandem mass spectrometry method for basic compounds: application to ephedrines in doping control analysis. , 2011, Journal of chromatography. A.
[455] R. Ventura,et al. Detection methods for autologous blood doping. , 2012, Drug testing and analysis.
[456] P. Marriott,et al. Evaluation of World Anti-Doping Agency criteria for anabolic agent analysis by using comprehensive two-dimensional gas chromatography–mass spectrometry , 2010, Analytical and bioanalytical chemistry.
[457] M. Saugy,et al. Investigations on carbon isotope ratios and concentrations of urinary formestane. , 2012, Drug testing and analysis.
[458] J. Crippa,et al. Why should Cannabis be Considered Doping in Sports? , 2013, Front. Psychiatry.
[459] L. Engebretsen,et al. Therapeutic use of growth factors in the musculoskeletal system in sports-related injuries. , 2009, The Journal of sports medicine and physical fitness.
[460] M. Saugy,et al. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples. , 2011, Forensic science international.
[461] M. Thevis,et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[462] M. Koupparis,et al. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin , 2010, Analytical and bioanalytical chemistry.
[463] M. Koupparis,et al. Stabilization of human urine doping control samples: II. microbial degradation of steroids. , 2009, Analytical biochemistry.
[464] C. Gore,et al. Stability of athlete blood passport parameters during air freight , 2014, International journal of laboratory hematology.
[465] S. Brandt,et al. AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis. , 2013, Drug testing and analysis.
[466] Neil Robinson,et al. The athlete's biological passport and indirect markers of blood doping. , 2010, Handbook of experimental pharmacology.
[467] T. Pottgiesser,et al. Current strategies of blood doping detection , 2013, Analytical and Bioanalytical Chemistry.
[468] M. Flueck,et al. A polymerase chain reaction-based methodology to detect gene doping , 2011, European Journal of Applied Physiology.
[469] E. Tudela,et al. Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. A.
[470] Chun-Chi Wang,et al. Analysis of anabolic androgenic steroids in urine by full-capillary sample injection combined with a sweeping CE stacking method , 2013, Analytical and Bioanalytical Chemistry.
[471] A. Leinonen,et al. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control. , 2013, Drug testing and analysis.
[472] F. Kobarfard,et al. Morphine/Codeine Ratio, a Key in Investigating a Case of Doping , 2015, Asian journal of sports medicine.
[473] M. Thevis,et al. Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing. , 2013, Methods in molecular biology.
[474] Perikles Simon,et al. A quantitative approach for assessing significant improvements in elite sprint performance: has IGF-1 entered the arena? , 2013, Drug testing and analysis.
[475] M. Schwarcz,et al. Growth Hormone and the Cardiovascular System , 2012, Cardiology in review.
[476] K. George,et al. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician , 2012, British Journal of Sports Medicine.
[477] C. Reichel. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control. , 2010, Drug testing and analysis.
[478] J. O'Brien,et al. 'Smoking' mephedrone: the identification of the pyrolysis products of 4-methylmethcathinone hydrochloride. , 2013, Drug testing and analysis.
[479] Ann I. Graul. Peginesatide for the treatment of anemia in the nephrology setting. , 2012, Drugs of today.
[480] D. Huckins,et al. Myocardial ischemia associated with clenbuterol abuse: report of two cases. , 2013, The Journal of emergency medicine.
[481] C. Cooper,et al. Drug cheating at the Olympics: who, what, and why? , 2012, The Lancet.
[482] M. Thevis,et al. AOD-9604 does not influence the WADA hGH isoform immunoassay. , 2013, Drug testing and analysis.
[483] Xiliang Luo,et al. The label free picomolar detection of insulin in blood serum. , 2013, Biosensors & bioelectronics.
[484] Martial Saugy,et al. Endogenous steroid profiling in the athlete biological passport. , 2010, Endocrinology and metabolism clinics of North America.
[485] P. Van Eenoo,et al. Fast quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THCA) using microwave-accelerated derivatisation and gas chromatography-triple quadrupole mass spectrometry. , 2013, Forensic science international.
[486] C. Goebel. Stimulating luteinizing hormone. , 2011, Drug testing and analysis.
[487] Martial Saugy,et al. A pilot study on subject‐based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports , 2011, Clinical endocrinology.
[488] P. Dargan,et al. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). , 2011, Drug testing and analysis.
[489] Ó. Pozo,et al. Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. , 2009, Drug testing and analysis.
[490] G. Rodchenkov,et al. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE. , 2015, Drug testing and analysis.
[491] Peter Prock,et al. Supplements and inadvertent doping - how big is the risk to athletes. , 2012, Medicine and sport science.
[492] T. Sobolevsky,et al. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[493] A. Butch,et al. Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control. , 2012, Methods in molecular biology.
[494] Lisi Zhang,et al. Detection of doping with rhGH: excretion study with WADA-approved kits. , 2011, Drug testing and analysis.
[495] M. Thevis,et al. Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience. , 2010, Drug testing and analysis.
[496] M. Duclos,et al. Why glucocorticoids ought to be kept on the World Antidoping Agency’s list of banned products , 2007, British Journal of Sports Medicine.
[497] X. de la Torre,et al. Metabolism of boldione in humans by mass spectrometric techniques: detection of pseudoendogenous metabolites. , 2013, Drug testing and analysis.
[498] R. Borges,et al. Salbutamol extraction from urine and its stability in different solutions: identification of methylation products and validation of a quantitative analytical method. , 2013, Biomedical chromatography : BMC.
[499] J. Travis. Pharmacology. Growth hormone test finally nabs first doper. , 2010, Science.
[500] P. Sönksen,et al. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes. , 2013, Drug testing and analysis.
[501] H. Haenssle,et al. The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder. , 2012, Archives of dermatology.
[502] L. Lipshultz,et al. Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility , 2014, Andrologia.
[503] J. Christiansen,et al. Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[504] H. Yoo,et al. LC-ESI/MS/MS method for rapid screening and confirmation of 44 exogenous anabolic steroids in human urine , 2011, Analytical and bioanalytical chemistry.
[505] S. Kageyama,et al. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[506] M. Zorzoli. The Athlete Biological Passport from the perspective of an anti-doping organization , 2011, Clinical chemistry and laboratory medicine.
[507] M. Galésio,et al. Matrix-assisted laser desorption/ionisation time of flight spectrometry for the fast screening of oxosteroids using aromatic hydrated hydrazines as versatile probes. , 2012, Talanta.
[508] M. Thevis,et al. Detection of testosterone esters in blood. , 2015, Drug testing and analysis.
[509] S. Reiken,et al. Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity , 2008, Proceedings of the National Academy of Sciences.
[510] A. Butch,et al. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample. , 2013, Drug testing and analysis.
[511] K. Graham,et al. The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes , 2010, Annals of Internal Medicine.
[512] M. Saugy,et al. Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing , 2013, Analytical and Bioanalytical Chemistry.
[513] D. Thieme,et al. Urinary concentrations of ethyl glucuronide and ethyl sulfate as thresholds to determine potential ethanol-induced alteration of steroid profiles. , 2011, Drug testing and analysis.
[514] Christopher R Harrison. Role of capillary electrophoresis in the fight against doping in sports. , 2013, Analytical chemistry.
[515] G. S. Bains,et al. Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system , 2010, Gene Therapy.
[516] E. Petricoin,et al. Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH. , 2009, Drug testing and analysis.
[517] J. Kurreck. RNA Interference: From Basic Research to Therapeutic Applications , 2009, Angewandte Chemie.
[518] H. Tobias,et al. Steroid isotopic standards for gas chromatography-combustion isotope ratio mass spectrometry (GCC-IRMS) , 2009, Steroids.
[519] Jingzhu Wang,et al. Influences of musk administration on the doping test , 2013, Steroids.
[520] P. Van Eenoo,et al. An improved gas chromatography screening method for doping substances using triple quadrupole mass spectrometry, with an emphasis on quality assurance. , 2012, Biomedical chromatography : BMC.
[521] M. Thevis,et al. Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. , 2012, Drug testing and analysis.
[522] S. Sánchez‐Cortés,et al. Adsorption of beta-adrenergic agonists used in sport doping on metal nanoparticles: a detection study based on surface-enhanced Raman scattering. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[523] M. Thevis,et al. Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis. , 2009, Drug testing and analysis.
[524] T. Kadowaki,et al. Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity , 2015, Diabetes & metabolism journal.
[525] K. Carlsen,et al. Two distinct phenotypes of asthma in elite athletes identified by latent class analysis , 2015, The Journal of asthma : official journal of the Association for the Care of Asthma.
[526] R. Wood,et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. , 2014, Endocrine reviews.
[527] M. Saugy,et al. Plasma and urine profiles of Δ9-tetrahydrocannabinol and its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes , 2010, Analytical and bioanalytical chemistry.
[528] M. Thevis,et al. Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry , 2015, Drug testing and analysis.
[529] S. Annaheim,et al. RhEPO improves time to exhaustion by non-hematopoietic factors in humans , 2016, European Journal of Applied Physiology.
[530] Simone Esposito,et al. Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products. , 2012, Rapid communications in mass spectrometry : RCM.
[531] S. Rudaz,et al. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports , 2015, Analytical and Bioanalytical Chemistry.
[532] A. Laggner,et al. Hypokalemic paralysis in a professional bodybuilder. , 2012, The American journal of emergency medicine.
[533] C. Georgakopoulos,et al. Sports doping: emerging designer and therapeutic β2-agonists. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[534] N. Robinson,et al. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport. , 2012, Drug testing and analysis.
[535] M. Schäfer,et al. Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control. , 2009, Rapid communications in mass spectrometry : RCM.
[536] Wilhelm Schänzer,et al. Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. , 2009, Drug testing and analysis.
[537] F. Botrè,et al. The abuse of diuretics as performance‐enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis , 2010, British journal of pharmacology.
[538] M. Thevis,et al. Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503. , 2009, Rapid communications in mass spectrometry : RCM.
[539] M. Zorzoli,et al. Case studies on ESA-doping as revealed by the Biological Passport. , 2012, Drug testing and analysis.
[540] D. Hughes. The World Anti-Doping Code in sport: Update for 2015. , 2015, Australian prescriber.
[541] D. Cowan,et al. Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone , 2009, Steroids.
[542] Wilhelm Schänzer,et al. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. , 2012, Methods.
[543] A. Sytkowski,et al. Erythropoietin and erythropoiesis stimulating agents. , 2012, Drug testing and analysis.
[544] M. Thevis,et al. Detection of Surreptitious Administration of Analog Insulin to an 8-Week-Old Infant , 2010, Pediatrics.
[545] K. Deventer,et al. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. , 2011, Journal of chromatography. A.
[546] Saskia S Sterk,et al. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays. , 2009, Analytica chimica acta.
[547] J. Naud,et al. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE. , 2013, Drug testing and analysis.
[548] Liang Tang,et al. Rapid and sensitive detection of β-agonists using a portable fluorescence biosensor based on fluorescent nanosilica and a lateral flow test strip. , 2013, Biosensors & bioelectronics.
[549] M. Thevis,et al. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis. , 2015, Drug testing and analysis.
[550] D. Thieme,et al. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control. , 2013, Drug testing and analysis.
[551] Markus Parzeller,et al. The punishment of gene doping - The relation between WADA prohibited lists, German Medicinal Products Act, German Doping Agents Amounts Ordinance, and Basic Law of the Federal Republic of Germany. , 2011, Drug testing and analysis.
[552] F. Donati,et al. A fast screening method for the detection of the abuse of hemoglobin-based oxygen carriers (HBOCs) in doping control. , 2010, Talanta.
[553] R. Jacobs,et al. Reticulocyte and haemoglobin profiles in elite triathletes over four consecutive seasons , 2011, International journal of laboratory hematology.
[554] L. Freeman,et al. Alternative medicine and doping in sports. , 2012, The Australasian medical journal.
[555] Suzanne Fergus,et al. Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues , 2011, Psychopharmacology.
[556] F. R. A. Aquino Neto,et al. Consequences of the formation of 3,4-dimethyl-5-phenyl-1,3-oxazolidine on the analysis of ephedrines in urine by gas chromatography and a new method for confirmation as N-trifluoroacetyl-O-t-butyldimethylsilyl ether derivatives. , 2011, Journal of chromatography. A.
[557] S. Mosler,et al. Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR , 2010, Molecular and Cellular Endocrinology.
[558] P. J. Elliot,et al. A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers , 2012, PloS one.
[559] J. Segura,et al. Tracking growth hormone abuse in sport: a comparison of distinct isoform-based assays. , 2012, Analytica chimica acta.
[560] V. Martínez-Bello,et al. PPARgamma agonist pioglitazone does not enhance performance in mice. , 2014, Drug testing and analysis.
[561] S. Bermon,et al. From Gene Engineering to Gene Modulation and Manipulation: Can We Prevent or Detect Gene Doping in Sports? , 2013, Sports Medicine.
[562] N. Baume,et al. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[563] F. Botrè,et al. Development and validation of a GC-C-IRMS method for the confirmation analysis of pseudo-endogenous glucocorticoids in doping control. , 2015, Drug testing and analysis.
[564] Martial Saugy,et al. Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports. , 2010, Drug testing and analysis.
[565] F. R. A. Aquino Neto,et al. Systematic analysis of glycerol: colourimetric screening and gas chromatography-mass spectrometric confirmation. , 2015, Drug testing and analysis.
[566] R. Wootton,et al. The naphyrone story: The alpha or beta-naphthyl isomer? , 2010, Drug testing and analysis.
[567] X. de la Torre,et al. Urine stability and steroid profile: towards a screening index of urine sample degradation for anti-doping purpose. , 2011, Analytica chimica acta.
[568] H. Geyer,et al. Degradation of urine samples and its influence on the ¹³C/¹²C ratios of excreted steroids. , 2010, Drug testing and analysis.
[569] P. Marriott,et al. Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control. , 2010, Journal of chromatography. A.
[570] M. Mascini,et al. Affinity sensing for transgenes detection in antidoping control. , 2009, Analytical chemistry.
[571] S. Sánchez‐Cortés,et al. Adsorption and detection of sport doping drugs on metallic plasmonic nanoparticles of different morphology. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[572] R. Di Santo,et al. Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[573] B. Adams,et al. Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). , 2012, Military medicine.
[574] J. Dvořák,et al. Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? , 2013, Rapid communications in mass spectrometry : RCM.
[575] N. Robinson,et al. How to confirm C.E.R.A. doping in athletes' blood? , 2011, Forensic science international.
[576] Daniel Umpierre,et al. Increased atherothrombotic markers and endothelial dysfunction in steroid users , 2013, European journal of preventive cardiology.
[577] M. Thevis,et al. Identification of human pituitary growth hormone variants by mass spectrometry. , 2009, Journal of proteome research.
[578] Vinod K. Gupta,et al. A sensitive voltammetric sensor for determination of synthetic corticosteroid triamcinolone, abused for doping. , 2009, Biosensors & bioelectronics.
[579] C. Saudan,et al. Detection in urine of 4-methyl-2-hexaneamine, a doping agent. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[580] Marilyn A Huestis,et al. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. , 2013, Analytical chemistry.
[581] E. Tudela,et al. In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. , 2013, Rapid communications in mass spectrometry : RCM.
[582] Martial Saugy,et al. Blood transfusion in sports. , 2010, Handbook of experimental pharmacology.
[583] M. Thevis,et al. Analytical challenges in the detection of peptide hormones for anti-doping purposes. , 2012, Bioanalysis.
[584] B. Friedmann-Bette,et al. Dependence of hemoglobin mass estimation with the optimized CO‐rebreathing method on different spectrophotometers , 2012, Scandinavian journal of medicine & science in sports.
[585] Ó. Pozo,et al. Alternative long-term markers for the detection of methyltestosterone misuse , 2013, Steroids.
[586] F. Lasne,et al. The problem of anti-doping control of luteinizing hormone in boxing. , 2013, Drug testing and analysis.
[587] J. Fisher. Landmark advances in the development of erythropoietin , 2010, Experimental biology and medicine.
[588] David T. Martin,et al. Stability of Hemoglobin Mass During a 6-Day UCI ProTour Cycling Race , 2010, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[589] E. Fornal. Study of collision-induced dissociation of electrospray-generated protonated cathinones. , 2014, Drug testing and analysis.
[590] N. Robinson,et al. The fight against doping: back on track with blood. , 2009, Drug testing and analysis.
[591] C J Gore,et al. Quality control technique to reduce the variability of longitudinal measurement of hemoglobin mass , 2011, Scandinavian journal of medicine & science in sports.
[592] A. George,et al. Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control. , 2012, Drug testing and analysis.
[593] M. Thevis,et al. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. , 2011, Rapid communications in mass spectrometry : RCM.
[594] J. Orchard. Why glucocorticoids should be removed from the World Antidoping Agency’s list of banned products , 2007, British Journal of Sports Medicine.
[595] M. Mazzarino,et al. A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS , 2008, Analytical and bioanalytical chemistry.
[596] J. Delanghe,et al. A rapid and simple assay to determine pegylated erythropoietin in human serum. , 2010, Journal of applied physiology.
[597] Ó. Pozo,et al. Alternative markers for the long-term detection of oral testosterone misuse , 2011, Steroids.
[598] C. Buisson,et al. Isotope ratio mass spectrometry analysis of the oxidation products of the main and minor metabolites of hydrocortisone and cortisone for antidoping controls , 2009, Steroids.
[599] P. Thirumalaikolundusubramanian,et al. Clinical, laboratory, and educational challenges of diuretic doping. , 2013, The American journal of emergency medicine.
[600] G. Banfi,et al. Reticulocytes in sports medicine: an update. , 2013, Advances in clinical chemistry.
[601] D. Zuba,et al. Prevalence and co-existence of active components of 'legal highs'. , 2013, Drug testing and analysis.
[602] F. Lasne,et al. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control , 2009, Haematologica.
[603] M. Hsu,et al. Liquid chromatography-tandem mass spectrometry screening method for the simultaneous detection of stimulants and diuretics in urine. , 2011, Journal of analytical toxicology.
[604] F. Botrè,et al. Analysis of stimulants in oral fluid and urine by gas chromatography-mass spectrometry II: pseudophedrine. , 2010, Journal of analytical toxicology.
[605] M. Thevis,et al. Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS , 2013, Analytical and Bioanalytical Chemistry.
[606] P. Prather,et al. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. , 2013, Toxicology and applied pharmacology.
[607] M. Thevis,et al. Plasticizers excreted in urine: indication of autologous blood transfusion in sports , 2012, Transfusion.
[608] J. Rupert,et al. Transcriptional profiling: a potential anti‐doping strategy , 2009, Scandinavian journal of medicine & science in sports.
[609] M. Mehlman. Genetic enhancement in sport: just another form of doping? , 2012, Recent patents on DNA & gene sequences.
[610] M. Thevis,et al. Seizures of doping substances at the Swiss Border--a descriptive investigation. , 2015, Forensic science international.
[611] S. Horning,et al. Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing. , 2013, Rapid communications in mass spectrometry : RCM.
[612] A. Miah. Genetics & sport: bioethical concerns. , 2012, Recent patents on DNA & gene sequences.
[613] Ioulietta Erotokritou-Mulligan,et al. The use of growth hormone (GH)‐dependent markers in the detection of GH abuse in sport: Physiological intra‐individual variation of IGF‐I, type 3 pro‐collagen (P‐III‐P) and the GH‐2000 detection score , 2010, Clinical endocrinology.
[614] Y O Schumacher,et al. Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes. , 2010, International journal of sports medicine.
[615] C. Creaser,et al. Application of mass spectrometry-based proteomics techniques for the detection of protein doping in sports , 2010, Expert review of proteomics.
[616] L A King,et al. Aminoindanes--the next wave of 'legal highs'? , 2011, Drug testing and analysis.
[617] C. Buisson,et al. Simultaneous quantification and qualification of synacthen in plasma , 2011, Analytical and bioanalytical chemistry.
[618] P. Teale,et al. Comparative in vitro metabolism of the ‘designer’ steroid estra-4,9-diene-3,17-dione between the equine, canine and human: Identification of target metabolites for use in sports doping control , 2010, Steroids.
[619] M. Thevis,et al. Mass spectrometric studies on the in vitro generated metabolites of SIRT1 activating drugs for doping control purposes. , 2013, Journal of mass spectrometry : JMS.
[620] E. Yanes,et al. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[621] J. Auwerx,et al. Pharmacological approaches to restore mitochondrial function , 2013, Nature Reviews Drug Discovery.
[622] F. Guan,et al. Identification of Darbepoetin Alfa in Human Plasma by Liquid Chromatography Coupled to Mass Spectrometry for Doping Control , 2009, International journal of sports medicine.
[623] M. Farré,et al. Fit-for-Purpose Radio Receptor Assay for the Determination of Growth Hormone Secretagogues in Urine , 2015, Journal of biomolecular screening.
[624] H. Geyer,et al. Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[625] Yu Bai,et al. Applications of ambient mass spectrometry in high-throughput screening. , 2013, The Analyst.
[626] U. Stenman,et al. Loss of human chorionic gonadotropin in urine during storage at -20°C. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[627] F. Botrè,et al. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[628] O. Rabin,et al. The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency. , 2011, Journal of analytical toxicology.
[629] J. Veuthey,et al. Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[630] Shahram Mohaghegh,et al. Doping and the Latest Prohibited List of the World Anti-Doping Agency (WADA) , 2013 .
[631] C. Reichel,et al. The interference of heparin on IEF-PAGE of erythropoietins. , 2010, Drug testing and analysis.
[632] Günter Gmeiner,et al. Defending Dynepo detection. , 2010, Drug testing and analysis.
[633] G. Baumann. Growth hormone doping in sports: a critical review of use and detection strategies. , 2012, Endocrine reviews.
[634] J. Barbosa,et al. Analysis of recombinant human erythropoietin glycopeptides by capillary electrophoresis electrospray-time of flight-mass spectrometry. , 2012, Analytica chimica acta.
[635] K. Ho,et al. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[636] X. de la Torre,et al. Analysis of exemestane and 17β-hydroxyexemestane in human urine by gas chromatography/mass spectrometry: development and validation of a method using MO-TMS derivatives. , 2010, Rapid communications in mass spectrometry : RCM.
[637] M. Thevis,et al. Mass spectrometric detection of siRNA in plasma samples for doping control purposes , 2010, Analytical and bioanalytical chemistry.
[638] Ó. Pozo,et al. Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment. , 2011, Drug testing and analysis.
[639] I. Erotokritou-Mulligan,et al. Insulin-like growth factor I and insulin and their abuse in sport. , 2010, Endocrinology and metabolism clinics of North America.
[640] T. D. Gauthier. Evidence for the Presence of 1,3-Dimethylamylamine (1,3-DMAA) in Geranium Plant Materials , 2013, Analytical chemistry insights.
[641] J. McKenna,et al. The search for size: a doping risk factor in adolescent rugby? , 2015, British Journal of Sports Medicine.
[642] David E. Smith,et al. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis , 2015, Journal of psychoactive drugs.
[643] P. Norsk,et al. Mechanisms and Management of Exercise-Induced Asthma in Elite Athletes , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.
[644] R. Bloomer,et al. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men , 2013, BMC Pharmacology and Toxicology.
[645] J. Rupert,et al. A DNA-based method for detecting homologous blood doping , 2013, Analytical and Bioanalytical Chemistry.
[646] H. Haisma,et al. Gene doping: an overview and current implications for athletes , 2013, British Journal of Sports Medicine.
[647] D. Cowan,et al. Doping in sport—1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone , 2009, Steroids.
[648] Martial Saugy,et al. Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion , 2013, PloS one.
[649] S. Kageyama,et al. Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography–tandem mass spectrometry , 2014, Analytical and Bioanalytical Chemistry.
[650] Y O Schumacher,et al. The Impact of Acute Gastroenteritis on Haematological Markers Used for the Athletes Biological Passport – Report of 5 cases , 2010, International journal of sports medicine.
[651] L. Ekström,et al. Androgens and doping tests: genetic variation and pit-falls. , 2012, British journal of clinical pharmacology.
[652] N. C. Sharp. The human genome and sport, including epigenetics, gene doping, and athleticogenomics. , 2010, Endocrinology and metabolism clinics of North America.
[653] J. V. Sancho,et al. Detection and Characterization of a New Metabolite of 17α-Methyltestosterone , 2009, Drug Metabolism and Disposition.
[654] M. Farré,et al. Evaluation of the urinary threshold concentration of formoterol in sports drug testing. , 2013, Drug testing and analysis.
[655] M. Saugy,et al. Blood monitoring of perfluorocarbon compounds (F-tert-butylcyclohexane, perfluoromethyldecalin and perfluorodecalin) by headspace-gas chromatography-tandem mass spectrometry. , 2015, Talanta.
[656] Roland P Archer,et al. Reference materials for new psychoactive substances. , 2011, Drug testing and analysis.
[657] D. B. Hibbert,et al. Systematic comparison of δ13C measurements of testosterone and derivative steroids in a freeze-dried urine candidate reference material for sports drug testing by gas chromatography/combustion/isotope ratio mass spectrometry and uncertainty evaluation using four different metrological approaches. , 2011, Rapid communications in mass spectrometry : RCM.
[658] P. Simon,et al. A quick one-tube nested PCR-protocol for EPO transgene detection. , 2012, Drug testing and analysis.
[659] F. Botrè,et al. Investigation on the application of DNA forensic human identification techniques to detect homologous blood transfusions in doping control. , 2013, Talanta.
[660] H. Tobias,et al. Calibration and data processing in gas chromatography combustion isotope ratio mass spectrometry. , 2012, Drug testing and analysis.
[661] M. Thevis,et al. Screening for benfluorex and its major urinary metabolites in routine doping controls , 2011, Analytical and bioanalytical chemistry.
[662] W. Schänzer,et al. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control. , 2009, Rapid communications in mass spectrometry : RCM.
[663] C. Reichel. SARCOSYL-PAGE: a new electrophoretic method for the separation and immunological detection of PEGylated proteins. , 2012, Methods in molecular biology.
[664] Philippe Schmitt-Kopplin,et al. Doping Control Using High and Ultra-High Resolution Mass Spectrometry Based Non-Targeted Metabolomics-A Case Study of Salbutamol and Budesonide Abuse , 2013, PloS one.
[665] M. Baumstark,et al. Gene expression in the detection of autologous blood transfusion in sports – a pilot study , 2009, Vox sanguinis.
[666] C. Saudan,et al. Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: international reference populations of professional soccer players , 2009, British Journal of Sports Medicine.
[667] Wilhelm Schänzer,et al. Doping control analysis of selected peptide hormones using LC-MS(/MS). , 2011, Forensic science international.
[668] A. Didier,et al. Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes , 2015, Respiratory Research.
[669] J. Carlsson,et al. Ultra-sensitive immunochromatographic assay for quantitative determination of erythropoietin. , 2008, Journal of immunological methods.
[670] Ying Dong,et al. An improved liquid chromatography-tandem mass spectrometric method to quantify formoterol in human urine. , 2014, Journal of chromatographic science.
[671] G. Baverel,et al. Study of a new indirect method based on absolute norms of variation to detect autologous blood transfusion , 2008, International journal of hematology.
[672] O. Rabin,et al. Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administration of pseudoephedrine-containing medications to healthy subjects: implications for doping control analysis of these stimulants banned in sport. , 2012, Drug testing and analysis.
[673] M. Bidlingmaier,et al. Detecting growth hormone abuse in athletes. , 2005, Endocrinology and metabolism clinics of North America.
[674] R. Damsgaard,et al. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers , 2011, Scandinavian journal of medicine & science in sports.
[675] M. Nielen,et al. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[676] A. Hoofnagle,et al. Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. , 2014, Clinical chemistry.
[677] A. Kubatiev,et al. High-temperature high-performance liquid chromatography on a porous graphitized carbon column coupled to an Orbitrap mass spectrometer with atmospheric pressure photoionization for screening exogenous anabolic steroids in human urine. , 2015, Rapid communications in mass spectrometry : RCM.
[678] C. Georgakopoulos,et al. Examination of the kinetic isotopic effect to the acetylation derivatization for the gas chromatographic-combustion-isotope ratio mass spectrometric doping control analysis of endogenous steroids. , 2012, Drug testing and analysis.
[679] V. Kouloulias,et al. Pheromones: a new ergogenic aid in sport? , 2015, International journal of sports physiology and performance.
[680] David A Cowan,et al. Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control. , 2013, Journal of chromatography. A.
[681] R. Oberhoffer,et al. Gene expression profiling in human whole blood samples after controlled testosterone application and exercise. , 2011, Drug testing and analysis.
[682] K. Patrick. Passport to clean competition , 2012, BMJ : British Medical Journal.
[683] F. Lasne,et al. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future. , 2012, Bioanalysis.
[684] H. Tobias,et al. Highly sensitive and selective analysis of urinary steroids by comprehensive two-dimensional gas chromatography combined with positive chemical ionization quadrupole mass spectrometry. , 2012, The Analyst.
[685] P. Van Eenoo,et al. beta-Adrenergic stimulation. , 2010, Handbook of experimental pharmacology.
[686] S. Catalano,et al. Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation , 2012, Molecular and Cellular Endocrinology.
[687] S. Shuster,et al. The banning of sportsmen and women who fail drug tests is unjustifiable. , 2013, The journal of the Royal College of Physicians of Edinburgh.
[688] T. Sobolevsky,et al. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. , 2012, Drug testing and analysis.
[689] G. Lippi,et al. Telmisartan as metabolic modulator: a new perspective in sports doping? , 2012, Journal of strength and conditioning research.
[690] Jorge Hallak,et al. Anabolic steroids and male infertility: a comprehensive review , 2011, BJU international.
[691] J. Grosse,et al. Olodaterol and vilanterol detection in sport drug testing. , 2015, Drug testing and analysis.
[692] S. Kageyama,et al. UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse. , 2013, Drug testing and analysis.
[693] W. Schänzer,et al. Effects of High Intensity Exercise on Isoelectric Profiles and SDS-PAGE Mobility of Erythropoietin , 2010, International journal of sports medicine.
[694] F. Buiarelli,et al. Determination of nandrolone metabolites in human urine: comparison between liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[695] F. Arioli,et al. Presence of endogenous prednisolone in human urine , 2013, Steroids.
[696] T. Wan,et al. Controlling the misuse of cobalt in horses. , 2015, Drug testing and analysis.
[697] M. Finel,et al. UDP-Glucuronosyltransferases (UGTs) 2B7 and UGT2B17 Display Converse Specificity in Testosterone and Epitestosterone Glucuronidation, whereas UGT2A1 Conjugates Both Androgens Similarly , 2009, Drug Metabolism and Disposition.
[698] J. Segura,et al. Surface plasmon resonance immuno assays - A perspective. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[699] E. Petricoin,et al. Analysis of urinary human growth hormone (hGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant hGH treatment: preliminary results. , 2013, Journal of pharmaceutical and biomedical analysis.
[700] M. Thevis,et al. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. , 2012, Drug testing and analysis.
[701] Tim James,et al. Ultrasensitive label free electrical detection of insulin in neat blood serum. , 2013, Analytical chemistry.
[702] P. Hemmersbach,et al. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.
[703] M. Thevis,et al. The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs) , 2013, Xenobiotica; the fate of foreign compounds in biological systems.
[704] P. Van Eenoo,et al. The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione , 2009, Drug Metabolism and Disposition.
[705] J. Coombes,et al. Glycerol use in hyperhydration and rehydration: scientific update. , 2012, Medicine and sport science.
[706] N. Ntoumanis,et al. What if it really was an accident? The psychology of unintentional doping , 2015, British Journal of Sports Medicine.
[707] M. Thevis,et al. Detection of the protease bacillolysin in doping-control urine samples. , 2009, Drug testing and analysis.
[708] T. Chapman,et al. Drug testing data from the 2007 Pan American Games: δ 13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[709] F. Botrè,et al. A rapid screening LC-MS/MS method based on conventional HPLC pumps for the analysis of low molecular weight xenobiotics: application to doping control analysis. , 2010, Drug testing and analysis.
[710] Ying Dong,et al. Mass spectrometric identification and characterization of new fluoxymesterone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry , 2012, Steroids.
[711] S. Lamon,et al. Rapid affinity purification of erythropoietin from biological samples using disposable monoliths. , 2010, Journal of chromatography. A.
[712] S. Shuster,et al. Testing athletes, and banning those who take drugs, is unjustifiable , 2012, BMJ : British Medical Journal.
[713] Ilkka Ojanperä,et al. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine , 2013, Analytical and Bioanalytical Chemistry.
[714] Giuseppe Lippi,et al. Altitude exposure in sports: the Athlete Biological Passport standpoint. , 2014, Drug testing and analysis.
[715] H. Geyer,et al. Determination of 13C/12C ratios of urinary epitestosterone and its main metabolites 5alpha- and 5beta-androstane-3alpha, 17alpha-diol. , 2009, Drug testing and analysis.
[716] W. Schänzer,et al. Optimizing SAR-PAGE. , 2015, Drug testing and analysis.
[717] M. Uhl,et al. Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry. , 2014, Drug testing and analysis.
[718] P. Sönksen,et al. GH & IGF Research issue on doping with growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[719] M. Penaud-Budloo,et al. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping , 2011, Gene Therapy.
[720] M. Thevis,et al. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.
[721] J. Muñoz-Guerra,et al. Use of hydrogen as a carrier gas for the analysis of steroids with anabolic activity by gas chromatography-mass spectrometry. , 2011, Journal of chromatography. A.
[722] Carol S. Lim,et al. The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications. , 2011, Journal of analytical toxicology.
[723] R. D. Blackledge. Bad science: the instrumental data in the Floyd Landis case. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[724] P. Restani,et al. Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin? , 2013, Drug testing and analysis.
[725] Gangfeng Ouyang,et al. Simultaneous analysis of fourteen tertiary amine stimulants in human urine for doping control purposes by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry. , 2010, Analytica chimica acta.
[726] Ray H. Liu,et al. Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis. , 2010, Journal of analytical toxicology.
[727] Ó. Pozo,et al. A new sulphate metabolite as a long-term marker of metandienone misuse , 2013, Steroids.
[728] K. Ho,et al. Growth hormone and physical performance , 2011, Trends in Endocrinology & Metabolism.
[729] H. Sachs,et al. Ethylglucuronide as a potential marker for alcohol-induced elevation of urinary testosterone/epitestosterone ratios. , 2009, Drug testing and analysis.
[730] J. Savulescu,et al. Should athletes be allowed to use performance enhancing drugs? , 2013, BMJ.
[731] S. Lamon,et al. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues. , 2010, Journal of pharmaceutical and biomedical analysis.
[732] N. Robinson,et al. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes. , 2010, Clinical laboratory.
[733] M. Thevis,et al. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. , 2015, Drug testing and analysis.
[734] G. Hoyer,et al. Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[735] M. Padilha,et al. Study of the endogenous steroid profile of male athletes from the Brazilian National Soccer Championship 2009. , 2010, Drug testing and analysis.
[736] V. Backer,et al. Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes. , 2014, Drug testing and analysis.
[737] M. Thevis,et al. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. , 2011, Drug testing and analysis.
[738] Jingzhu Wang,et al. Profiling of urinary steroids by gas chromatography–mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry , 2011, Steroids.
[739] M. Thevis,et al. Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO. , 2013, Journal of pharmaceutical and biomedical analysis.
[740] M. Gütschow,et al. In vitro synthesis and characterisation of three fenoterol sulfoconjugates detected in fenoterol post-administration urine samples , 2013, Analytical and Bioanalytical Chemistry.
[741] P. Teale,et al. Impact of the emergence of designer drugs upon sports doping testing , 2009 .
[742] Keith Baar,et al. Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases , 2012, Cell.